Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel

Biochemical and Biophysical Research Communications

Volumn 401, Issue 1, 2010, Pages 58-63

  Pielak, Rafal M ^a   Chou, James J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Flu drug resistance; Influenza M2; Proton channel; V27A mutant

Indexed keywords

AMANTADINE; PROTEIN M2; RIMANTADINE;

ALLOSTERISM; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG BINDING; HYDROPHOBICITY; INFLUENZA VIRUS A; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON TRANSPORT; WILD TYPE;

ALANINE; AMINO ACID SUBSTITUTION; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, SECONDARY; VALINE; VIRAL MATRIX PROTEINS;

INFLUENZA A VIRUS;

EID: 77957653235     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.008     Document Type: Article

References (30)

1. Hay A.J., Wolstenholme A.J., Skehel J.J., Smith M.H. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 1985, 4:3021-3024.
2. Helenius A. Unpacking the incoming influenza virus. Cell 1992, 69:577-578.
3. Pinto L.H., Holsinger L.J., Lamb R.A. Influenza virus M2 protein has ion channel activity. Cell 1992, 69:517-528.
4. Davies W.L., Grunert R.R., Haff R.F., McGahen J.W., Neumayer E.M., Paulshock M., Watts J.C., Wood T.R., Hermann E.C., Hoffmann C.E. Antiviral activity of 1-adamantanamine (amantadine). Science 1964, 144:862-863.
5. Bright R.A., Shay D.K., Shu B., Cox N.J., Klimov A.I. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006, 295:891-894.
6. Hay A.J., Zambon M.C., Wolstenholme A.J., Skehel J.J., Smith M.H. Molecular basis of resistance of influenza A viruses to amantadine. J. Antimicrob. Chemother. 1986, 18(Suppl. B):19-29.
7. Wang C., Takeuchi K., Pinto L.H., Lamb R.A. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J. Virol. 1993, 67:5585-5594.
8. Bright R.A., Medina M.J., Xu X., Perez-Oronoz G., Wallis T.R., Davis X.M., Povinelli L., Cox N.J., Klimov A.I. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005, 366:1175-1181.
9. Deyde V.M., Xu X., Bright R.A., Shaw M., Smith C.B., Zhang Y., Shu Y., Gubareva L.V., Cox N.J., Klimov A.I. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J. Infect. Dis. 2007, 196:249-257.
10. Krumbholz A., Schmidtke M., Bergmann S., Motzke S., Bauer K., Stech J., Durrwald R., Wutzler P., Zell R. High prevalence of amantadine resistance among circulating European porcine influenza A viruses. J. Gen. Virol. 2009, 90:900-908.
11. Anton A., Marcos M.A., Martinez M.J., Ramon S., Isanta R., de Molina P., de Anta M.T., Pumarola T. Double (V27A/S31N) mutant 2009 pandemic influenza A (H1N1) virus isolated from adamantane non-treated inmunocompetent child. Diagn. Microbiol. Infect. Dis. 2010, 67:114-115.
12. Astrahan P., Kass I., Cooper M.A., Arkin I.T. A novel method of resistance for influenza against a channel-blocking antiviral drug. Proteins 2004, 55:251-257.
13. Kovacs F.A., Denny J.K., Song Z., Quine J.R., Cross T.A. Helix tilt of the M2 transmembrane peptide from influenza A virus: an intrinsic property. J. Mol. Biol. 2000, 295:117-125.
14. Wang J., Kim S., Kovacs F., Cross T.A. Structure of the transmembrane region of the M2 protein H(+) channel. Protein Sci. 2001, 10:2241-2250.
15. Stouffer A.L., Acharya R., Salom D., Levine A.S., Di Costanzo L., Soto C.S., Tereshko V., Nanda V., Stayrook S., DeGrado W.F. Structural basis for the function and inhibition of an influenza virus proton channel. Nature 2008, 451:596-599.
16. Schnell J.R., Chou J.J. Structure and mechanism of the M2 proton channel of influenza A virus. Nature 2008, 451:591-595.
17. Cady S.D., Schmidt-Rohr K., Wang J., Soto C.S., Degrado W.F., Hong M. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature 2010, 463:689-692.
18. Andreas L.B., Eddy M.T., Pielak R.M., Chou J., Griffin R.G. Magic angle spinning NMR investigation of influenza A M2(18-60): support for an allosteric mechanism of inhibition. J. Am. Chem. Soc. 2010, 132:10958-10960.
19. Pielak R.M., Schnell J.R., Chou J.J. Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc. Natl. Acad. Sci. USA 2009, 106:7379-7384.
20. R.M. Pielak, J.J. Chou, Influenza M2 proton channels, Biochim. Biophys. Acta (2010), doi:. doi:10.1016/j.bbamem.2010.04.015.
21. Sugrue R.J., Belshe R.B., Hay A.J. Palmitoylation of the influenza A virus M2 protein. Virology 1990, 179:51-56.
22. Ohigashi Y., Ma C., Jing X., Balannick V., Pinto L.H., Lamb R.A. An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition. Proc. Natl. Acad. Sci. USA 2009, 106:18775-18779.
23. Du Q.S., Huang R.B., Wang C.H., Li X.M., Chou K.C. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus. J. Theor. Biol. 2009, 259:159-164.
24. Pielak R.M., Chou J.J. Flu channel drug resistance: a tale of two sites. Protein Cell 2010, 1:246-258.
25. Schroeder C., Ford C.M., Wharton S.A., Hay A.J. Functional reconstitution in lipid vesicles of influenza virus M2 protein expressed by baculovirus: evidence for proton transfer activity. J. Gen. Virol. 1994, 75(Pt. 12):3477-3484.
26. + exchange transporter by polyatomic anions. J. Mol. Biol. 2006, 362:682-690.
27. Moffat J.C., Vijayvergiya V., Gao P.F., Cross T.A., Woodbury D.J., Busath D.D. Proton transport through influenza A virus M2 protein reconstituted in vesicles. Biophys. J. 2008, 94:434-445.
28. Salzmann M., Wider G., Pervushin K., Wuthrich K. Improved sensitivity and coherence selection for [N-15, H-1]-TROSY elements in triple resonance experiments. J. Biomol. NMR 1999, 15:181-184.
29. Kay L.E., Ikura M., Tschudin R., Bax A. Three-dimensional triple resonance NMR spectroscopy of isotopically enriched proteins. J. Magn. Reson. 1990, 89:496-514.
30. Schwieters C.D., Kuszewski J., Tjandra N., Clore G.M. The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 2002, 160:66-74.